SBFM Sunshine Biopharma: Company Short-Term Debts

Symbol and logo of brand Sunshine Biopharma (SBFM)

Demand for oncology care remains stable regardless of economic conditions, and therefore the price evolution of Sunshine Biopharma (SBFM) is recorded below. The current figure is 0.00. The business relies on a combination of Canadian generic sales and high-risk development of new molecules. Meanwhile, the staff is being expanded with research chemists who are incentivized by royalty bonuses and stock option programs.

SBFM sunshinebiopharma.com Company Short-Term Loans and Borrowings (07/04/2022 - 10/31/2026)

SBFM (Sunshine Biopharma Inc.): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price Sunshine Biopharma, Inc.|SBFM - Consensus Target
- company stock capitalization data:
Market Capitalization Sunshine Biopharma, Inc.|SBFM - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Sunshine Biopharma|SBFM - Accounting Value of Company|Market Cap to Net Assets Ratio sunshinebiopharma.com|SBFM - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital Sunshine Biopharma|SBFM - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Sunshine Biopharma|SBFM - Company Aggregate Debts|Debt to Book Capitalization Ratio Sunshine Biopharma, Inc.|SBFM - Company Long-Term Loans and Borrowings|Company Short-Term Debts Sunshine Biopharma|Quick Liquidity sunshinebiopharma.com
- earnings and multiples data:
SBFM - Net Financial Result
Analysis of all company metrics:SBFM - Sunshine Biopharma, Inc.
Manufactured products of sunshinebiopharma.com

This indicator measures the volume of liabilities with a maturity of up to one year, allowing for an assessment of liquidity and the risk of working capital shortages during a sharp deleveraging. By analyzing the size of short-term borrowed capital, an investor can determine the financial stability of Sunshine Biopharma (SBFM), whose oncology development expenditures remain stable regardless of macroeconomic cycles and GDP fluctuations.

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|candeltx.com (CADL) - Company Short-Term Debt|Accuray Inc - Company Short-Term Loans and Borrowings|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Short-Term Debt Actuate Therapeutics Inc ACTU|Company Short-Term Debt Citius Oncology, Inc. (CTOR)|Short-Term Debt Volume tuhurabio.com|Protara Therapeutics, Inc. - Company Current Liabilities|Company Short-Term Debts Fate Therapeutics Inc FATE|WHWK - Company Short-Term Debt|TCRX (TScan Therapeutics) - Company Short-Term Indebtedness|championsoncology.com (CSBR) - Company Short-Term Debt|XBIT - Short-Term Debt Volume|CVM (CEL-SCI Corp.) - Company Short-Term Debts|OSTX: Company Short-Term Loans and Borrowings|Company Short-Term Debts RADX|Short-Term Debt Volume artivabio.com|Company Short-Term Debt Adlai Nortye ANL|VERU: Company Short-Term Indebtedness|Tempest Therapeutics, Inc. - Company Short-Term Debts|Short-Term Debt Xilio Therapeutics, Inc.|RENB (renovarobio.com) - Company Current Liabilities|Mural Oncology - Company Short-Term Loans and Borrowings|KAPA (Kairos Pharma Limited) - Company Short-Term Debts|Company Short-Term Debt OKUR|Company Short-Term Debts GDTC|Short-Term Debt Volume curis.com|Company Short-Term Debt Apollomics APLM|Tharimmune Corporation (THAR) - Short-Term Debt|ADVB - Company Short-Term Debt|Current Liabilities GNPX|CLDI: Company Short-Term Debts|Xenetic Biosciences, Inc. - Company Short-Term Loans and Borrowings|SLRX (Salarius) - Company Short-Term Debts|Company Short-Term Debts Kitov Pharma|Company Short-Term Debt American Oncology Network (AONC)|BGNE (beigene.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Checkpoint Therapeutics, Inc. CKPT|ELEV - Company Current Liabilities|iCAD Corp - Company Short-Term Debts|IKNA - Company Short-Term Debts|Notable Labs, Ltd. (NTBL) - Company Short-Term Debt|VIRX - Short-Term Debt Volume|MOR (MorphoSys) - Company Short-Term Debts|Company Short-Term Debt NAYA|Company Short-Term Debts AAPGV